A 82-year-old male patient with metastatic lung adenocarcinoma presented to the outpatient clinic at the University of Texas MD Anderson Cancer Center (Houston, TX, USA) in April, 2015 with worsening fatigue, headache, dizziness, blurry vision, and nausea. He had received treatment with an immune checkpoint inhibitor, ipilimumab (an anti CTLA-4 antibody) 4 weeks before presentation. A brain MRI showed a diffuse pituitary enlargement in the T1-weighted coronal section (figure, A) and sagittal section (figure, B), with increased thickening of the pituitary stalk and enhancement of adjacent dura, suggestive of hypophysitis.
http://ift.tt/2FytnTa
Τετάρτη 31 Ιανουαρίου 2018
[Clinical Picture] Autoimmune hypophysitis
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου